Covetrus, Inc.
CVETNASDAQHealthcare
$20.99
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$21.2
52W Low$13.39
Covetrus, Inc. (CVET) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CVET · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2022Report Date: Aug 4, 2022EPS Actual
$0.25
Est. $0.25 · +0.0%
Revenue
$1.22B
Fiscal Period
Q3 FY2022
FY ends December
Report Date
Aug 4, 2022
After Market Close
🔥 11-Quarter EPS Beat Streak
CVET reports quarterly as a NASDAQ-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2022 | Nov 2, 2022 | $0.27 | — | — | — | $1.22B | — |
| — Q3 FY2022 | Aug 4, 2022 | $0.25 | $0.25 | +0.0% | $1.22B | — | — |
| ▲ Q2 FY2022 | May 5, 2022 | $0.22 | $0.25 | +13.6% | $1.15B | $1.15B | -0.5% |
| ▲ Q1 FY2022 | Feb 24, 2022 | $0.25 | $0.26 | +4.0% | $1.12B | $1.14B | -1.2% |
| — Q4 FY2021 | Nov 4, 2021 | $0.23 | $0.23 | +0.0% | $1.16B | $1.17B | -0.3% |
| ▲ Q3 FY2021 | Aug 5, 2021 | $0.24 | $0.26 | +8.3% | $1.19B | $1.16B | +2.6% |
| ▲ Q2 FY2021 | May 6, 2021 | $0.17 | $0.21 | +23.5% | $1.10B | $1.09B | +1.2% |
| ▲ Q1 FY2021 | Mar 1, 2021 | $0.16 | $0.21 | +31.3% | $1.12B | $1.05B | +6.4% |
Q4 FY2022
Nov 2, 2022
EPS Actual
—
EPS Est.
$0.27
EPS Surpr.
—
Revenue
—
Q3 FY2022
Aug 4, 2022
EPS Actual
$0.25
EPS Est.
$0.25
EPS Surpr.
+0.0%
Revenue
$1.22B
Q2 FY2022
May 5, 2022Beat
EPS Actual
$0.25
EPS Est.
$0.22
EPS Surpr.
+13.6%
Revenue
$1.15B
Q1 FY2022
Feb 24, 2022Beat
EPS Actual
$0.26
EPS Est.
$0.25
EPS Surpr.
+4.0%
Revenue
$1.12B
Q4 FY2021
Nov 4, 2021
EPS Actual
$0.23
EPS Est.
$0.23
EPS Surpr.
+0.0%
Revenue
$1.16B
Q3 FY2021
Aug 5, 2021Beat
EPS Actual
$0.26
EPS Est.
$0.24
EPS Surpr.
+8.3%
Revenue
$1.19B
Q2 FY2021
May 6, 2021Beat
EPS Actual
$0.21
EPS Est.
$0.17
EPS Surpr.
+23.5%
Revenue
$1.10B
Q1 FY2021
Mar 1, 2021Beat
EPS Actual
$0.21
EPS Est.
$0.16
EPS Surpr.
+31.3%
Revenue
$1.12B
No analyst estimates available for CVET.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2022 | Aug 4, 2022 | +0.0% | $20.79 | $20.80 | +0.05% |
| ▲ Q2 FY2022 | May 5, 2022 | +13.6% | $15.09 | $13.98 | -7.36% |
| ▲ Q1 FY2022 | Feb 24, 2022 | +4.0% | $16.97 | $17.50 | +3.12% |
| ▲ Q4 FY2021 | Nov 4, 2021 | +0.0% | $19.85 | $19.11 | -3.73% |
| ▲ Q3 FY2021 | Aug 5, 2021 | +8.3% | $24.95 | $25.31 | +1.44% |
| ▲ Q2 FY2021 | May 6, 2021 | +23.5% | $30.53 | $30.06 | -1.54% |
| ▲ Q1 FY2021 | Mar 1, 2021 | +31.3% | $37.16 | $34.13 | -8.15% |
| ▲ Q4 FY2020 | Nov 10, 2020 | +44.4% | $26.63 | $26.01 | -2.33% |
Q3 FY2022+0.05%
Report Date
Aug 4, 2022
EPS Beat/Miss
+0.0%
Price Before
$20.79
Price After
$20.80
Q2 FY2022-7.36%
Report Date
May 5, 2022
EPS Beat/Miss
+13.6%
Price Before
$15.09
Price After
$13.98
Q1 FY2022+3.12%
Report Date
Feb 24, 2022
EPS Beat/Miss
+4.0%
Price Before
$16.97
Price After
$17.50
Q4 FY2021-3.73%
Report Date
Nov 4, 2021
EPS Beat/Miss
+0.0%
Price Before
$19.85
Price After
$19.11
Q3 FY2021+1.44%
Report Date
Aug 5, 2021
EPS Beat/Miss
+8.3%
Price Before
$24.95
Price After
$25.31
Q2 FY2021-1.54%
Report Date
May 6, 2021
EPS Beat/Miss
+23.5%
Price Before
$30.53
Price After
$30.06
Q1 FY2021-8.15%
Report Date
Mar 1, 2021
EPS Beat/Miss
+31.3%
Price Before
$37.16
Price After
$34.13
Q4 FY2020-2.33%
Report Date
Nov 10, 2020
EPS Beat/Miss
+44.4%
Price Before
$26.63
Price After
$26.01
Avg Beat Reaction-2.31%
Beat Rate8 / 8 quarters
Largest Move-8.15% (Q1 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CVET ends December
Covetrus, Inc. (CVET) most recently reported earnings on August 4, 2022 for Q3 FY2022, posting EPS of $0.25 (in line with the analyst consensus of $0.25). CVET has beaten EPS estimates for 11 consecutive quarters. The next CVET earnings date is expected around September 1, 2026.
Each quarter, investors track CVET earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CVET revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CVET's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CVET earnings · 4 questionsCovetrus, Inc.'s next earnings report is expected around September 1, 2026. CVET typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CVET historically reports after market close (AMC).
CVET earnings datewhen is CVET earningsCVET next earnings datewhen does CVET report earningsCVET earnings calendar
▸ Source: FMP · Covetrus, Inc. SEC filings · US GAAP · Covetrus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026